MLMarcos Antonio Pereira de Lima

Marcos Antonio Pereira de Lima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marcos Antonio Pereira de Lima has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Coinfection of Leprosy and American Cutaneous Leishmaniasis: A Case Report From Ceará, Brazil

    by Moacir Pereira Leite Neto, Jordannia Oliveira Fernandes, Ana Carolina Carvalho Ferraz, Julia Graziele Alves Marelli, Marcos Antônio Pereira de Lima, Cláudio Gleidiston Lima da Silva, Ligia Regina Franco Sansigolo Kerr, Ricardo Queiroz Gurgel

    Leprosy and American cutaneous leishmaniasis are endemic diseases in Brazil that may coexist in the same host, particularly in coendemic regions. We report the case of a 68‐year‐old woman presenting with a six‐month history of an ulcerated lesion on the left knee and concomitant disseminated annular plaques associated with sensory loss, madarosis, and peripheral nerve thickening. Histopathological examination of the ulcer demonstrated findings compatible with cutaneous leishmaniasis; immunohistochemistry using CD1a highlighted structures compatible with amastigotes, acknowledging its limitations. Biopsy of the plaques revealed a chronic granulomatous dermatitis with numerous acid‐fast bacilli, corroborating multibacillary leprosy in the appropriate clinical context. The patient was treated with multidrug therapy for leprosy and intralesional meglumine antimoniate for leishmaniasis, with favorable outcomes. To the best of our knowledge, this is the first published report of such coinfection in Ceará. This case highlights the importance of sampling lesions with distinct morphologies and integrating clinical, histopathological, and laboratory findings in endemic settings.

  • Epstein-barr virus (EBV) in cervical carcinoma detected by in situ hybridization targeting ebers and the viral genome

    by Álife Diêgo Lima Silva, Julia Graziele Alves Marelli, Maria Willaiara Lira Lopes, Myrella Tavares Rodrigues, Cecília Paz Lopes, José Nairton Coelho Silva, Sávio Samuel Feitosa Machado, Racquel Oliveira da Silva Souza, Maria Aparecida Tibúrcio, Alexandre Quental Sampaio, et al.

    Epstein-Barr virus (EBV) infection has been suggested as a potential cofactor for the development and progression of cervical cancer, collaborating with high-risk Human Papillomavirus (HR-HPV). In situ hybridization (ISH) has been considered the gold standard in the investigation of EBV in neoplasms. This study aimed to detect EBV in cervical carcinoma samples using ISH targeting EBERs (EBER-ISH) and the BamHI-W region of the viral genome (BamHI-W-ISH), and compare the results of both targets. Of the 88 cases collected, 9 were EBER-ISH positive (10.2%), while 33 (37.5%) cases were positive for EBV by BamHI-W-ISH, all showing staining in the nuclei of the malignant cells. No statistically significant results were found between the presence of EBV and carcinoma type, differentiation grade or tumor staging. The kappa agreement index between the two targets was 0.092. Only 4 cases were EBER-ISH(+) and BamHI-W-ISH(–). On the other hand, 28 cases were BamHI-W-ISH(+) and EBER-ISH(–). Altogether, 37/88 (42%) cases were EBV-positive by one or both targets. Infected lymphocytes were verified in 9 (10.2%) and 34 (38.6%) cases, by EBER-ISH and BamHI-W-ISH, respectively. The slight agreement demonstrated between the targets may be due to the lack of expression of EBERs, suggesting that EBV may present a distinct latency pattern in the cervical mucosa, or that it has entered the replicative cycle in some of these tumors, in both cases, explaining the low positivity rate verified through EBER-ISH, while calling into question the latter’s gold standard status in the detection of EBV in malignancies. Our findings also indicate that the chosen viral genomic target may represent a suitable candidate for EBV detection by ISH.


  • Open Access

    ASPECTOS CLÍNICO-EPIDEMIOLÓGICOS DA FEBRE MACULOSA BRASILEIRA: UMA PERSPECTIVA CONTEMPORÂNEA

    by Francisco Wallace Bezerra Salviano, João Emanuel Braga Amaro Vieira, Beatriz Cândido Monteiro da Silva, Argemiro Érick Landim Grangeiro, Bianka Nascimento Lima, José Paulo Dos Santos Neto, Marcos Antônio Pereira de Lima, Cláudio Gleidiston Lima da Silva, Maria Do Socorro Vieira dos Santos

    Introduction: Brazilian Spotted Fever (BSF) is an infectious disease transmitted by ticks of the genus Amblyomma, whose main etiological agent is the bacterium Rickettsia rickettsii, manifesting itself through an acute febrile condition. Objective: This narrative review aimed to address the epidemiological and clinical aspects of Brazilian Spotted Fever in Brazil. Methodology: A descriptive study with a retrospective approach carried out through a literature search based on data obtained from articles available free of charge in the Medline, PubMed, Scopus and SciELO databases, published from 2013 to 2023. In order to address the main theme more broadly, gray literature and data from the Notifiable Diseases Information System - SINAN were also used, which were statically analyzed using the Epi Info and BioEstat programs. Results and Discussion: In Brazil, the main species of tick vectors of Rickettsia rickettsii, obligate intracellular Gram-negative bacilli that cause Rocky Mountain spotted fever are Amblyomma cajennense and A. aureolatum. Retrospective analysis of SINAN data found an average of 163.7 cases and a lethality of 31.6. The epidemiological study found a higher incidence and mortality from FMB in the Southeast Region, mainly in white men aged 20 to 60 years. Variables such as gender, race, age group, site of infection and macro-region were also relevant in the study. Prominent symptoms include fever, headache and myalgia, and may present a broad clinical spectrum with severe cases. Serology is the basis of diagnosis and indirect immunofluorescence is the preferred test. The treatment of choice is doxycycline from the tetracycline group. Conclusion: Early detection and appropriate treatment are important to reduce morbidity and mortality from tick-borne pathogens. Introdução: A Febre Maculosa Brasileira (FMB) é uma doença infecciosa transmitida por carrapatos do gênero Amblyomma, tendo como principal agente etiológico a bactéria Rickettsia rickettsii, manifestando-se por um quadro febril agudo. Objetivo: A presente revisão narrativa teve por objetivo abordar os aspectos epidemiológicos e clínicos da Febre Maculosa Brasileira no Brasil. Metodologia: Estudo de caráter descritivo e abordagem retrospectiva realizado por meio de uma pesquisa de literatura a partir dos dados obtidos em artigos disponíveis free no banco de dados Medline, PubMed, Scopus e SciELO, publicados no período de 2013 a 2023. Além disso, no intuito de abordar a temática principal de forma mais ampla, também se utilizou a literatura cinzenta e dados do Sistema de Informação de Agravos de Notificação – SINAN, os quais foram analisados estaticamente por meio dos programas Epi Info e BioEstat. Resultados e Discussão: No Brasil, as principais espécies de carrapatos vetores da Rickettsia rickettsii, bacilos Gram-negativos intracelulares obrigatórios, causadora da febre maculosa são a Amblyomma cajennense e a A. aureolatum. A análise retrospectiva dos dados do SINAN constatou uma média de 163,7 casos e uma letalidade de 31,6. O estudo epidemiológico constatou uma maior incidência e mortalidade por FMB na Região Sudeste, principalmente em homens brancos com idade de 20 a 60 anos. Variáveis como sexo, raça, faixa etária, local de infecção e macrorregião também se mostraram relevantes no estudo. Os sintomas proeminentes incluem febre, cefaléia e mialgia, podendo apresentar um amplo espectro clínico com casos graves. A sorologia é a base do diagnóstico e a imunofluorescência indireta é o teste de preferência. O tratamento de escolha é a doxiciclina do grupo das tetraciclinas. Conclusão: A detecção precoce e o tratamento adequado são importantes para reduzir a morbidade e a mortalidade por patógenos transmitidos por carrapatos.


  • Open Access

    Epstein-Barr Virus-Associated Carcinoma of the Larynx: A Systematic Review with Meta-Analysis

    by Marcos Antonio Pereira de Lima, Álife Diêgo Lima Silva, Antônio Carlos Silva Do Nascimento Filho, Thiago Lima Cordeiro, João Pedro de Souza Bezerra, Maria Aline Barroso Rocha, Sally de França Lacerda Pinheiro, Roberto Flávio Fontenelle Pinheiro Junior, Maria Do Socorro Vieira Gadelha, Cláudio Gleidiston Lima da Silva

    Over the past few decades, several publications have investigated the role of Epstein-Barr virus (EBV) in head and neck squamous cell carcinomas, and an increasing number of them have shown its presence in laryngeal tumors. The purpose of this meta-analysis was to evaluate the association of EBV with laryngeal carcinoma. The search was carried out in two databases, Scopus and PubMed, using the following terms: “Epstein-Barr virus” and “laryngeal carcinoma”. A total of 187 records were found, of which 31 were selected for meeting the inclusion and exclusion criteria. The meta-analysis yielded an overall pooled prevalence of 43.72% (95% confidence interval (CI): 34.35–53.08). Studies carried out in Europe and Eurasia had slightly higher pooled prevalence than other subgroups, while the prevalence of studies performed in developed countries was higher than in developing countries (46.37% vs. 34.02%). Furthermore, laryngeal carcinoma occurred almost three times as often among EBV-infected individuals compared to those without EBV infection (odds ratio = 2.86 (95% CI: 1.18–6.90); Begg’s test, p = 0.843 and Egger’s test, p = 0.866). Our findings support the idea that EBV is related to laryngeal carcinoma. However, further studies are needed before recognizing a definitive etiological role of EBV in the development and/or progression of laryngeal carcinomas.


  • Evaluation of HPV and EBV in OSCC and the expression of p53, p16, E‐cadherin, COX‐2, MYC, and MLH1

    by Marcos Antonio Pereira de Lima, Roberta Barroso Cavalcante, Cláudio Gleidiston Lima da Silva, Renato Luiz Maia Nogueira, Geamberg Einstein Cruz Macedo, Lara Eduardo de Galiza, Juliana Viana Pinheiro, Pedro Hugo Bezerra Maia Filho, Sarah Ferreira Santos, Silvia Helena Barem Rabenhorst

    Objective: This study aimed to evaluate the presence of human papillomavirus (HPV) and Epstein–Barr virus (EBV) and the expression of p53, p16, E‐cadherin, COX‐2, MLH1, and MYC in oral squamous cell carcinoma (OSCC).Materials and Methods: One hundred OSCC specimens were submitted to in situ hybridization for HPV and EBV, and immunohistochemistry for detection of the human proteins.Results: Thirty‐one cases showed HPV in tumor tissue. EBV was not detected in any case investigated. The HPV(+) group demonstrated an increase of staining scores for nuclear p16 (p = .047), cytoplasmic MYC (p = .002), while a decrease for nuclear MLH1 (p = .048), suggesting that HPV may upregulate the expression of the first two proteins and down‐regulate the latter.Conclusion: Our findings reinforce the hypothesis of the HPV‐related oral carcinogenesis involving the expression of p16 and MYC, and MLH1 suppression. Exclusively cytoplasmic stainings for p16, MLH1, and MYC were also associated with more advanced tumors. Finally, in view of the lack of studies correlating the HPV or EBV infection to the expression of oncoproteins, more researches assessing a broader panel of markers and employing different approaches are still necessary in order to understand the role of these viruses as well as the molecular mechanisms involved in the development and progression of oral carcinomas.


  • Characterization of the sand fly fauna in Barbalha, one of the municipalities with the highest leishmaniasis rates in Brazil

    by Raimundo Diego Ferreira Amorim, Marcos Antônio Pereira de Lima, Racquel Oliveira da Silva Souza, Ulisses Mariano da Silva, Antônio Pereira dos Santos, Ana Paula Tavares, Maria Do Socorro Vieira Gadelha, Cláudio Gleidiston Lima da Silva


  • Epidemiology and Etiopathogeny of COVID-19

    by Modesto Leite Rolim Neto, Claúdio Gleidiston Lima da Silva, Maria Do Socorro Vieira dos Santos, Estelita Lima Cândido, Marcos Antônio Pereira de Lima, Sally de França Lacerda Pinheiro, Roberto Flávio Fontenelle Pinheiro Junior, Claudener Souza Teixeira, Sávio Samuel Feitosa Machado, Luiz Fellipe Gonçalves Pinheiro, et al.

    Despite the recent announcement of the new pathogenic coronavirus to man, SARS-CoV2, a large number of publications are presented to the scientific community. An organized and systematic review of the epidemiological, etiological, and pathogenic factors of COVID-19 is presented. This is a systematic review using the databases MEDLINE, EMBASE, Web of Science, SCIELO; the descriptors coronavirus, SARS-CoV-2, etiology, epidemiology, pathophysiology, pathogenesis, COVID-19, with publications from December 2019 to January 2021, resulting in more than 800 publications and 210 selected. The data suggest that COVID-19 is associated with SAR-CoV-2 infection, with the transmission of contagion by fomites, salivary droplets, and other forms, such as vertical and fecal–oral. The bat and other vertebrates appear to be reservoirs and part of the transmission chain. The virus uses cell receptors to infect human cells, especially ACE2, like other coronaviruses. Heat shock proteins have different roles in the infection, sometimes facilitating it, sometimes participating in more severe conditions, when not serving as a therapeutic target. The available data allow us to conclude that COVID-19 is a pandemic viral disease, behaving as a challenge for public health worldwide, determining aggressive conditions with a high mortality rate in patients with risk factors, without treatment, but with the recent availability of the first vaccines.

  • Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Oral and Anogenital Carcinogenesis: Potential Tumorigenic Pathways

    by Marcos Antonio Pereira de Lima, Ilara Parente Pinheiro Teodoro, Cláudio Gleidiston Lima da Silva, Marcos Venício Alves Lima

    Epstein-Barr virus (EBV) and human papillomavirus (HPV) have been implicated in 38% of all virus-related cancers. Over the past three decades, both have been detected in anogenital and head-and-neck squamous cell carcinomas (HNSCC), with evidence of involvement in tumor genesis and progression. Very little has been published on HPV/EBV coinfection. In this chapter, we review the literature on the role of these viruses in oral carcinoma and draw parallels with other HNSCCs and anogenital carcinomas, with emphasis on their interplay and potential signaling pathways. EBV infection seems to create an environment that favors HPV latency, supporting the claim that EBV is a cofactor in HPV-related carcinomas. In turn, under certain circumstances, HPV appears to be able to induce EBV to switch to the latent or replicative state. The main viral oncogenes expressed in these malignancies are EBNA1, EBNA2, LMP1, EBERs, and the high-risk HPV oncogenes E6 and E7. The most well-documented human proteins involved are p53, pRb, p16INK4a, p19ARF, Myc, E-cadherin, β-catenin, EGFR, MLH1, and COX-2. These proteins are directly associated not only with viral products but also with one another in the development of malignancy. Knowledge of the molecular machinery behind carcinomas coinfected with HPV and EBV may help understand how these viruses trigger carcinogenesis and subsidize the development of new biomarkers of tumor aggressiveness and prognosis, alternative surrogate virus markers, and possible therapeutic targets.


  • Preface: Epstein–Barr Virus and Oncogenesis

    by Marcos Antonio Pereira de Lima, Heberty Tarso Facundo

  • Association between Epstein-Barr Virus and Oral Carcinoma: A Systematic Review with Meta-Analysis

    by Marcos Antonio Pereira de Lima, Ilara Parente Pinheiro Teodoro, Lara Eduardo de Galiza, Pedro Hugo Bezerra Maia Filho, Fernanda de Morais Marques, Roberto Flávio Fontenelle Pinheiro, Geamberg Einstein Cruz Macedo, Heberty Tarso Facundo, Cláudio Gleidiston Lima da Silva, Marcos Venício Alves Lima

    The purpose of this meta-analysis is to evaluate the association of Epstein-Barr virus (EBV) with oral squamous cell carcinoma (OSCC). We searched the electronic scientific databases of PubMed and Scopus and included a total of 53 studies that were published from 1990 to 2019. The analysis yielded a 45.37% (95% confidence interval [CI]: 38.90-51.84; p < 0.001) overall pooled prevalence of EBV. Studies that used the applied methods of in situ hybridization, polymerase chain reaction, immunology, or RNA microarray showed the following pooled prevalence: 46.08%, 40.32, 54.97%, and 74.89%, respectively. EBV-infected individuals have a 2.5 higher risk for developing OSCC (odds ratio: 2.57; 95% CI: 1.23% to 5.36%; p < 0.001). The present meta-analysis supports the hypothesis of EBV association with OSCC, pointing to this virus as a risk factor for neoplasia. Our findings also suggest that EBV latent transcripts (latent membrane protein 1, EBV nuclear antigen 1 and 2, and EBV-encoded small RNAs) have an important role in this process. Furthermore, novel advancements could arise from large and standardized studies that are constructed to probe for other latent gene expression, eliminate confounding factors (tobacco, alcohol, and high-risk human papillomavirus infection), and define the relationship between EBV and oral carcinomas.